2013
DOI: 10.1016/j.jash.2013.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Sarcopenic obesity as an independent risk factor of hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
67
0
5

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 104 publications
(75 citation statements)
references
References 18 publications
3
67
0
5
Order By: Relevance
“…Sarcopenia, the age-related decline in muscle mass and strength, may represent one possible mechanism through which hypertension accelerates functional declines – though this potential is presently speculative given the limited evidence in this area. Several studies from Asian populations have recently demonstrated a cross-sectional link between hypertension and sarcopenia (Han et al, 2014; Park et al, 2013; Wu et al, 2014), while a longitudinal cohort study in Finish individuals reported hypertension as a significant predictor of muscle strength decline over 22 years of follow-up (Stenholm et al, 2012). This potential acceleration of sarcopenia could result in response to hypertension-mediated increases in inflammation and oxidative stress (as discussed above) – key molecular contributors to the development and progression of sarcopenia (Buford et al, 2010; Marzetti et al, 2013; Roubenoff, 2003).…”
Section: Collateral Health Risks Among Older Adults With Hypertensionmentioning
confidence: 99%
“…Sarcopenia, the age-related decline in muscle mass and strength, may represent one possible mechanism through which hypertension accelerates functional declines – though this potential is presently speculative given the limited evidence in this area. Several studies from Asian populations have recently demonstrated a cross-sectional link between hypertension and sarcopenia (Han et al, 2014; Park et al, 2013; Wu et al, 2014), while a longitudinal cohort study in Finish individuals reported hypertension as a significant predictor of muscle strength decline over 22 years of follow-up (Stenholm et al, 2012). This potential acceleration of sarcopenia could result in response to hypertension-mediated increases in inflammation and oxidative stress (as discussed above) – key molecular contributors to the development and progression of sarcopenia (Buford et al, 2010; Marzetti et al, 2013; Roubenoff, 2003).…”
Section: Collateral Health Risks Among Older Adults With Hypertensionmentioning
confidence: 99%
“…Several cross-sectional studies in Korean populations of older adults have found that sarcopenic obese individuals had the worse cardiovascular risk profile. Sarcopenic obesity (based on skeletal muscle assessed by DXA and obesity measured by either computerised tomography, DXA, BMI or WC) was associated with lower cardiorespiratory fitness, higher fasting glucose levels, a higher risk of hypertension, dyslipidaemia and insulin resistance, and up to an 8-fold increase in risk of the metabolic syndrome compared with non-sarcopenic, non-obese (48)(49)(50)(51)(52)(53)(54)(55) . Similar findings were reported in a community-dwelling sample of Taiwanese older adults; sarcopenic obesity (defined by BIA-measured muscle mass and BMI) was associated with the highest risk of metabolic syndrome (56) .…”
Section: Sarcopenic Obesity and Cardiovascular Risk Factorsmentioning
confidence: 99%
“…9 Obesity has long been established as an important and independent risk factor for the development and complication of hypertension. [10][11][12] Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) and waist-hip ratio (WHR) are simple and valid anthropometric measures for the assessment of obesity and risk of hypertension. 13,14 Ageing population, rapid urbanization and transition from agrarian life to a wage-earning, modern city life are reported as major contributors to increased unhealthy life style pattern in urban areas.…”
Section: Introductionmentioning
confidence: 99%